Download PDFPDF
Concordant chromosome 3 results in paired choroidal melanoma biopsies and subsequent tumour resection specimens
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Genetic Testing for Chromosomal Aberration in Choroidal Melanoma
    • Kakarla V. Chalam, Chairman
    • Other Contributors:
      • Khaled K. Abu-Amero, Krishna Mynampati Bharani and Kakarla V. Chalam

    The authors have investigated the and compared the chromosome 3 aberrations of Choroidal melanoma (CM) as determined by multiplex ligation probe amplification (MLPA) or microsatellite analysis (MSA)in intra ocular tumor biopsies with those results obtained from subsequent endoresection/enucleation of the same Choroidal melanoma. However few points need clarification from the authors: 1. Since the investigators used few ma...

    Show More
    Conflict of Interest:
    None declared.